Array Biopharma, Investors Agree To $8.5M Settlement Deal
Array Biopharma Inc. has agreed to pay $8.5 million to settle claims it failed to properly detail its efforts to secure U.S. Food and Drug Administration approval for a new skin...To view the full article, register now.
Already a subscriber? Click here to view full article